Which regimens do not require dose adjustment for the treatment of hepatitis C virus (HCV) infection in patients with eGFR 30 mL/min or higher?

Updated: Dec 09, 2020
  • Author: David C Wolf, MD, FACP, FACG, AGAF, FAASLD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Answer

See the following regimens:

  • Daily fixed-dose combination of elbasvir (50 mg)/grazoprevir (100 mg) [29]
  • Daily fixed-dose combination of glecaprevir (300 mg)/pibrentasvir (120 mg) [30]
  • Fixed-dose combination of ledipasvir (90 mg)/sofosbuvir (400 mg) [31]
  • Fixed-dose combination of sofosbuvir (400 mg)/velpatasvir (100 mg) [32]
  • Fixed-dose combination of sofosbuvir (400 mg)/velpatasvir (100 mg)/voxilaprevir (100 mg) [33]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!